Table 3 |
|||||
|
Methodological quality of systematic reviews and randomised trials primary studies included in this study. |
|||||
|
Systematic review |
AMSTAR |
Quality Score (Percent of maximum) |
Primary study |
SIGN 50* |
Percent quality |
|
|
|||||
|
Pegurri et al 2004 [3] |
1. No |
18% |
Brugha 1996 [22] |
6/10 |
60% |
|
2. No |
|||||
|
3. Yes |
|||||
|
4. No |
|||||
|
5. No |
|||||
|
6. No |
|||||
|
7. Yes |
|||||
|
8. No |
|||||
|
9. Can't answer |
|||||
|
10. No |
|||||
|
11. No |
|||||
|
Batt 2004 [14] |
1. No |
27% |
Andersson 2008 [6] |
6/10 |
60% |
|
2. No |
|||||
|
3. Yes |
|||||
|
4. Yes |
|||||
|
5. No |
|||||
|
6. No |
|||||
|
7. Yes |
|||||
|
8. Can't answer |
|||||
|
9. Can't answer |
|||||
|
10. No |
|||||
|
11. No |
|||||
|
Haines 2007 [15] |
1. No |
18% |
|||
|
2. No |
|||||
|
3. Yes |
|||||
|
4. yes |
|||||
|
5. No |
|||||
|
6. No |
|||||
|
7. No |
|||||
|
8. No |
|||||
|
9. No |
|||||
|
10. No |
|||||
|
11. No |
|||||
|
Ryman 2008 [5] |
1. No |
36% |
|||
|
2. No |
|||||
|
3. Yes |
|||||
|
4. Yes |
|||||
|
5. No |
|||||
|
6. Yes |
|||||
|
7. Yes |
|||||
|
8. No |
|||||
|
9. Can't answer |
|||||
|
10. No |
|||||
|
11. No |
|||||
|
|
|||||
|
* Scores based on the first 10 items (internal validity) of the SIGN 50 Instrument http://www.sign.ac.uk/guidelines/fulltext/50/checklist2.html webcite. |
|||||
|
Shea et al. BMC International Health and Human Rights 2009 9(Suppl 1):S5 doi:10.1186/1472-698X-9-S1-S5 |
|||||